AF.56 COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. (September 2021) - Maniero, D.; Lorenzon, G.; Marsilio, I.; Rigo, A.; Cardin, R.; Facchin, S.; Barberio, B.; D'Incà, R.; Zingone, F.; Bahur, B.; Bray, K.; Savarino, E.V.